{"id":"placebo-to-losartan-potassium","safety":{"commonSideEffects":[{"rate":"4-10%","effect":"Dizziness"},{"rate":"3-6%","effect":"Headache"},{"rate":"2-5%","effect":"Fatigue"},{"rate":"2-5%","effect":"Cough"},{"rate":"2-5%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This results in decreased peripheral resistance and a subsequent decrease in blood pressure. Losartan also has a mild diuretic effect, which helps to reduce fluid volume and further lower blood pressure.","oneSentence":"Losartan potassium is an angiotensin II receptor antagonist that blocks the action of angiotensin II at its receptor in the blood vessels, causing them to relax and dilate, which lowers blood pressure and reduces the workload on the heart.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:44.036Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Diabetic nephropathy"}]},"trialDetails":[{"nctId":"NCT07449000","phase":"NA","title":"Losartan for Corneal Fibrosis","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2026-02-12","conditions":"Corneal Scarring Fibrosis","enrollment":46},{"nctId":"NCT06933706","phase":"PHASE2","title":"Losartan to Improve Outcomes After Multi-ligament Knee Injury","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-01","conditions":"Multi-ligament Knee Injury","enrollment":90},{"nctId":"NCT07135687","phase":"PHASE4","title":"Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-08","conditions":"ACL Injury, ACL Reconstruction, Scar Formation","enrollment":144},{"nctId":"NCT05619653","phase":"PHASE3","title":"Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valentina Puentmann","startDate":"2022-12-12","conditions":"COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular","enrollment":279},{"nctId":"NCT06624904","phase":"EARLY_PHASE1","title":"Losartan and Social Processing","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-19","conditions":"Social Cognition","enrollment":68},{"nctId":"NCT04715568","phase":"PHASE4","title":"Secondhand Tobacco Smoke and Cardiovascular Disease","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-03-30","conditions":"Cardiovascular Diseases, Hypertension","enrollment":100},{"nctId":"NCT04632589","phase":"EARLY_PHASE1","title":"Losartan for Improved Vascular Endothelial Function After Preeclampsia","status":"COMPLETED","sponsor":"Anna Stanhewicz, PhD","startDate":"2020-11-22","conditions":"Preeclampsia Postpartum","enrollment":11},{"nctId":"NCT06636812","phase":"EARLY_PHASE1","title":"Losartan and Emotional Processing in Young People","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-07","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT06364176","phase":"PHASE2","title":"Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2024-06-03","conditions":"Cystic Fibrosis","enrollment":42},{"nctId":"NCT02235909","phase":"PHASE3","title":"An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension","status":"COMPLETED","sponsor":"Arbor Pharmaceuticals, Inc.","startDate":"2015-03-30","conditions":"Hypertension","enrollment":377},{"nctId":"NCT06628154","phase":"EARLY_PHASE1","title":"Losartan and Emotional Learning","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-14","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT05637216","phase":"PHASE2","title":"Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients","status":"RECRUITING","sponsor":"Shaw Cancer Center","startDate":"2023-08-17","conditions":"Radiation Induced Fibrosis","enrollment":40},{"nctId":"NCT00140907","phase":"PHASE4","title":"ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-03-14","conditions":"High Blood Pressure","enrollment":367},{"nctId":"NCT01277822","phase":"PHASE4","title":"Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-05-30","conditions":"Hypertension","enrollment":334},{"nctId":"NCT00447603","phase":"PHASE3","title":"A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-24","conditions":"Hypertension","enrollment":40},{"nctId":"NCT00568178","phase":"PHASE3","title":"An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06-01","conditions":"Proteinuria","enrollment":306},{"nctId":"NCT01307046","phase":"PHASE3","title":"MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":336},{"nctId":"NCT01307033","phase":"PHASE3","title":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":278},{"nctId":"NCT00090259","phase":"PHASE3","title":"Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-12-19","conditions":"Heart Failure","enrollment":3834},{"nctId":"NCT02676466","phase":"PHASE2","title":"The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-04-26","conditions":"Inflammation","enrollment":289},{"nctId":"NCT02263729","phase":"PHASE1, PHASE2","title":"Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains","status":"TERMINATED","sponsor":"James J. Irrgang","startDate":"2016-08-10","conditions":"Hamstring Injury","enrollment":8},{"nctId":"NCT04815902","phase":"PHASE1, PHASE2","title":"Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-05-18","conditions":"Osteoarthritis, Knee","enrollment":100},{"nctId":"NCT05025956","phase":"PHASE1, PHASE2","title":"Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-10-24","conditions":"Femoroacetabular Impingement","enrollment":68},{"nctId":"NCT06329076","phase":"NA","title":"Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT04212650","phase":"PHASE1, PHASE2","title":"Losartan to Improve Hip Microfracture","status":"TERMINATED","sponsor":"Steadman Philippon Research Institute","startDate":"2020-08-07","conditions":"Hip Osteoarthritis, Hip Impingement Syndrome, Cartilage Damage","enrollment":1},{"nctId":"NCT01845688","phase":"NA","title":"Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"wanglin","startDate":"2011-11","conditions":"Idiopathic Membranous Nephropathy","enrollment":72},{"nctId":"NCT03632213","phase":"PHASE2","title":"Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2018-11-07","conditions":"Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, Mucopolysaccharidoses","enrollment":10},{"nctId":"NCT03897868","phase":"PHASE2","title":"A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2019-03-21","conditions":"Hypertension","enrollment":248},{"nctId":"NCT02696564","phase":"PHASE4","title":"Losartan Effects on Emphysema Progression","status":"COMPLETED","sponsor":"JHSPH Center for Clinical Trials","startDate":"2017-05-23","conditions":"Emphysema","enrollment":220},{"nctId":"NCT04394117","phase":"PHASE4","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","status":"COMPLETED","sponsor":"The George Institute","startDate":"2020-06-19","conditions":"Coronavirus Disease 2019, COVID-19","enrollment":787},{"nctId":"NCT00092209","phase":"PHASE3","title":"Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-04","conditions":"Hypertension","enrollment":840},{"nctId":"NCT00308347","phase":"PHASE3","title":"A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1996-05","conditions":"Type 2 Diabetes, Nephropathy","enrollment":1513},{"nctId":"NCT00943852","phase":"PHASE1","title":"The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-08","conditions":"Hypertension","enrollment":13},{"nctId":"NCT00289887","phase":"PHASE3","title":"Obese Hypertension Study (0954-315)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-02","conditions":"Hypertension","enrollment":261},{"nctId":"NCT03467217","phase":"PHASE2","title":"Losartan for the Treatment of Pediatric NAFLD","status":"TERMINATED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2018-10-02","conditions":"NAFLD - Nonalcoholic Fatty Liver Disease","enrollment":83},{"nctId":"NCT04238702","phase":"PHASE4","title":"Renohemodynamic Effects of Combined empagliflOzin and LosARtan","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2020-11-04","conditions":"Diabetes Mellitus, Type 2, Diabetic Kidney Disease","enrollment":24},{"nctId":"NCT00720577","phase":"EARLY_PHASE1","title":"Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.","status":"COMPLETED","sponsor":"Medtronic Endovascular","startDate":"2005-12","conditions":"Peripheral Arterial Disease","enrollment":164},{"nctId":"NCT00340678","phase":"PHASE3","title":"Renoprotection in Early Diabetic Nephropathy in Pima Indians","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1995-08","conditions":"Diabetic Nephropathy","enrollment":170},{"nctId":"NCT01852942","phase":"PHASE2","title":"Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-09","conditions":"HIV Infection, HIV Infections","enrollment":52},{"nctId":"NCT03206788","phase":"PHASE2","title":"Losartan and Inflammation in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Miami","startDate":"2017-11-11","conditions":"Cystic Fibrosis","enrollment":7},{"nctId":"NCT03335904","phase":"PHASE4","title":"AT1R Blockade and Periodic Breathing During Sleep in Hypoxia","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2018-01-01","conditions":"Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder","enrollment":14},{"nctId":"NCT01637623","phase":"PHASE2","title":"Study of Cardiovascular Disease and Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2012-06","conditions":"Severe Obstructive Sleep Apnea (Apnea Hypopnea Index > 30 Events/Hour), Hypertension","enrollment":87},{"nctId":"NCT04278495","phase":"NA","title":"The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2014-09-01","conditions":"Losartan Adverse Reaction, Uropathy, Uropathy Obstructive","enrollment":96},{"nctId":"NCT02049307","phase":"PHASE2","title":"Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial","status":"COMPLETED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2014-10-16","conditions":"Inflammation, Fibrosis","enrollment":108},{"nctId":"NCT04078711","phase":"PHASE2, PHASE3","title":"Chinese Medicine Treat for Hypertensive Renal Injury","status":"UNKNOWN","sponsor":"Jiangsu Province Hospital of Traditional Chinese Medicine","startDate":"2019-09-10","conditions":"Hypertension, Renal Injury","enrollment":520},{"nctId":"NCT01302691","phase":"PHASE3","title":"MK-0954E Study in Participants With Hypertension (MK-0954E-357)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-01","conditions":"Hypertension","enrollment":327},{"nctId":"NCT00981747","phase":"PHASE2, PHASE3","title":"Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis","status":"TERMINATED","sponsor":"Alicia Gerke","startDate":"2009-09","conditions":"Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis","enrollment":12},{"nctId":"NCT02232763","phase":"PHASE3","title":"Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-09","conditions":"Proteinuria","enrollment":58},{"nctId":"NCT01033318","phase":"PHASE1","title":"A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-09-11","conditions":"Hypertension","enrollment":30},{"nctId":"NCT00675987","phase":"PHASE4","title":"A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2007-05","conditions":"Obesity, Hypertension, Hyperglycemia","enrollment":53},{"nctId":"NCT01292694","phase":"PHASE1","title":"Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure","status":"TERMINATED","sponsor":"Vanderbilt University","startDate":"2011-03","conditions":"Hypertension, Pure Autonomic Failure, Multiple System Atrophy","enrollment":12},{"nctId":"NCT01989793","phase":"PHASE2","title":"A Study of Muscle Strength Maintenance in Older Adults","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-07","conditions":"Sarcopenia","enrollment":37},{"nctId":"NCT03434054","phase":"NA","title":"The Effect of Losartan on Emotional Processing in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-06-01","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT03357653","phase":"PHASE3","title":"Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1","status":"UNKNOWN","sponsor":"Ewha Womans University","startDate":"2018-01-30","conditions":"Glomerulonephritis, Immunoglobulin A (IgA)","enrollment":174},{"nctId":"NCT00067990","phase":"PHASE4","title":"Angiotensin II Blockade for Chronic Allograft Nephropathy","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2002-12","conditions":"Kidney Disease, Proteinuria","enrollment":153},{"nctId":"NCT01913470","phase":"PHASE2","title":"Study of Losartan in the Treatment of NAFLD in Children","status":"COMPLETED","sponsor":"Miriam Vos, MD","startDate":"2013-07","conditions":"NAFLD","enrollment":12},{"nctId":"NCT02232880","phase":"PHASE2","title":"Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2014-08","conditions":"Hypertension","enrollment":1},{"nctId":"NCT00344110","phase":"PHASE3","title":"Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-06","conditions":"Hypertension","enrollment":768},{"nctId":"NCT00856960","phase":"PHASE1","title":"The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-01","conditions":"Hypertension","enrollment":12},{"nctId":"NCT00763893","phase":"PHASE3","title":"Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-09","conditions":"Marfan Syndrome","enrollment":303},{"nctId":"NCT01051219","phase":"PHASE3","title":"Anti-Fibrotic Effects of Losartan In Nash Evaluation Study","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2011-05","conditions":"Nonalcoholic Steatohepatitis","enrollment":45},{"nctId":"NCT01541943","phase":"PHASE3","title":"Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia","status":"COMPLETED","sponsor":"HanAll BioPharma Co., Ltd.","startDate":"2012-03","conditions":"Essential Hypertension, Hyperlipidemia","enrollment":356},{"nctId":"NCT00886600","phase":"PHASE3","title":"A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1991-05","conditions":"Hypertension","enrollment":122},{"nctId":"NCT00882440","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1990-12","conditions":"Hypertension","enrollment":576},{"nctId":"NCT02446548","phase":"NA","title":"Influence of Aliskiren on Albuminuria After Kidney Transplantation","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2013-03","conditions":"Albuminuria","enrollment":18},{"nctId":"NCT00280215","phase":"PHASE3","title":"Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2007-12","conditions":"Hyperoxaluria","enrollment":""},{"nctId":"NCT02200653","phase":"PHASE4","title":"A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-05","conditions":"Hypertension","enrollment":387},{"nctId":"NCT02200640","phase":"PHASE4","title":"A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-03","conditions":"Hypertension","enrollment":333},{"nctId":"NCT02183701","phase":"PHASE3","title":"Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-04","conditions":"Hypertension","enrollment":715},{"nctId":"NCT01398423","phase":"PHASE2","title":"INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria","status":"COMPLETED","sponsor":"InVasc Therapeutics, Inc.","startDate":"2011-06","conditions":"Hypertension, Diabetes Mellitus, Type 2","enrollment":88},{"nctId":"NCT00275639","phase":"PHASE4","title":"The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2004-12","conditions":"Liver Transplant Recipients","enrollment":62},{"nctId":"NCT00219141","phase":"PHASE3","title":"Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-10","conditions":"Hypertension, Left Ventricular Hypertrophy, Overweight","enrollment":460},{"nctId":"NCT00734630","phase":"PHASE4","title":"Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-08","conditions":"Hypertension","enrollment":491},{"nctId":"NCT01305850","phase":"PHASE4","title":"The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2010-07","conditions":"Peritoneal Membrane Failure","enrollment":100},{"nctId":"NCT00949884","phase":"PHASE4","title":"Olmesartan Comparison to Losartan in Hypertensive Subjects","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2009-08","conditions":"Hypertension","enrollment":941},{"nctId":"NCT00151827","phase":"PHASE3","title":"Olmesartan Medoxomil in Hypertension and Renal Impairment","status":"COMPLETED","sponsor":"Sankyo Pharma Gmbh","startDate":"2003-08","conditions":"Essential Hypertension, Renal Impairment","enrollment":393},{"nctId":"NCT01041963","phase":"PHASE4","title":"The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2009-06","conditions":"Continuous Ambulatory Peritoneal Dialysis","enrollment":90},{"nctId":"NCT00647257","phase":"NA","title":"The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome","status":"UNKNOWN","sponsor":"Chung Shan Medical University","startDate":"2008-04","conditions":"Atrial Fibrillation","enrollment":220},{"nctId":"NCT00381134","phase":"PHASE2","title":"Improving Outcomes in Patients With Kidney Disease Due to Diabetes","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2003-07","conditions":"Diabetes, Kidney Disease, Hypertension","enrollment":92},{"nctId":"NCT00887250","phase":"PHASE3","title":"A Study to Investigate the Antihypertensive Efficacy of MK0954","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1991-12","conditions":"Hypertension","enrollment":366},{"nctId":"NCT00888355","phase":"PHASE3","title":"MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1992-05","conditions":"Hypertension","enrollment":428},{"nctId":"NCT00160225","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension","status":"COMPLETED","sponsor":"Solvay Pharmaceuticals","startDate":"2005-07","conditions":"Hypertension","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo to losartan potassium","genericName":"Placebo to losartan potassium","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Losartan potassium is an angiotensin II receptor antagonist that blocks the action of angiotensin II at its receptor in the blood vessels, causing them to relax and dilate, which lowers blood pressure and reduces the workload on the heart. Used for Hypertension, Diabetic nephropathy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}